Does use of flue-cured rather than blended cigarettes affect international variation in mortality from lung cancer and COPD?

Inhalation Toxicology

Volumn 21, Issue 5, 2009, Pages 404-430

  Lee, Peter N ^a   Forey, Barbara A ^a   Fry, John S ^a   Hamling, Jan S ^a   Hamling, John F ^a   Sanders, Edward B ^b   Carchman, Richard A ^c  

^a P N Lee Statistics and Computing Ltd   (United Kingdom)

^b Philip Morris Products SA   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MALE; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; UNITED KINGDOM; UNITED STATES;

ADULT; AGED; FEMALE; HUMANS; INTERNATIONALITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; TOBACCO INDUSTRY; WORLD HEALTH;

EID: 70350594380     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370802317737     Document Type: Article

References (34)

1. Baker, R. R., Massey, E. D., and Smith, G. 2004. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 42S:S53-S83. (Pubitemid 38456980)
2. Carmines, E. L. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 1: Cigarette design, testing approach, and review of results. Food Chem. Toxicol. 40:77-91.
3. Forey, B., Hamling, J., Lee, P., and Wald, N., eds. 2002. International smoking statistics. A collection of historical data from 30 economically developed countries, 2nd ed. London and Oxford: Wolfson Institute of Preventive Medicine and Oxford University Press. Errata available at http://www.pnlee.co. uk/ISS2.htm.
4. Forey, B., and Lee, P. 2002. Estimation of sex-specific smoking statistics by standardized age groups and time periods. Supplement 1 to International smoking statistics, A collection of historical data from 30 economically developed countries (2nd edition). Sutton, Surrey: P N Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download ISS2suppl1 FOREY2002C]
5. Forey, B. A., Hamling, J., and Hamling, J. 2006. Deriving estimates of exsmoking prevalence. Sutton, Surrey: P N Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download FOREY2006]
6. Forey, B. A., Hamling, J., and Lee, P. N. 2007. International mortality and smoking statistics IMASS Version 4.02. Sutton, Surrey: P N Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/IMASS.htm
7. Friedman, G. D., Tekawa, I., Sadler, M., and Sidney, S. 1997. Smoking and mortality: the Kaiser Permanente experience. In Changes in cigaretterelated disease risks and their implications for prevention and control, pp. 477-499. Smoking and Tobacco Control. Monograph No. 8, eds.
8. Shopland D. R., D. M. Burns, L. Garfinkel, and Samet J. M.. (NIH Pub. No. 97-4213.) Rockville, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. http://cancercontrol.cancer. gov/tcrb/monographs/8/m8-6.pdf
9. Lange, P., Nyboe, J., Appleyard, M., Jensen, G., and Schnohr, P. 1992. Relationship of the type of tobacco and inhalation pattern to pulmonary and total mortality. Eur. Respir. J. 5:1111-1117.
10. Lee, P. N., and Forey, B. A. 2003. How do lung cancer rates in never smokers vary by country? P.N. Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/ reflist.htm [Download LEE2003O].
11. Lee, P. N., and Forey, B. A. 2006. Indirectly estimated absolute lung cancer rates in ever smokers and never smokers by gender, region, year and histological type. P.N. Lee Statistics and Computing Ltd. http://www. pnlee.co.uk/reflist.htm [Download LEE2006M].
12. Lee, P. N., Forey, B. A., and Young, K. J. 2003a. International evidence on smoking and lung cancer (project IESLC). A first report. Part I: The databases, methods used to collect and analyse the data and scope of the information obtained. P.N. Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download LEE2003J].
13. Lee, P. N., Forey, B. A., and Young, K. J. 2003b. International evidence on smoking and lung cancer (project IESLC). A first report. Part II: Results of selected meta-analyses. P.N. Lee Statistics and Computing Ltd. http:// www.pnlee.co.uk/reflist.htm [Download LEE2003K].
14. Legg, P. D., and Smeeton, B. W. 1999. 2. Breeding and genetics. In Tobacco production, chemistry, and technology, eds. D. L. Davis, and M. T. Nielson, pp. 32-48. Oxford: Blackwell Science.
15. Lemus, R., Carmines, E. L., Van Miert, E., Coggins, C. R. E. , Anskeit, E., Gerstenberg, B., Meisgen, T. J., Schramke, H., Stabbert, R., Völkel, H., and Terpstra, P. M. 2007. Toxicological comparisons of cigarettes containing different amounts of vanillin. Inhal. Toxicol. 19:683-699.
16. Pauwels, R. A., and Rabe, K. F. 2004. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613-620.
17. Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., and Doll, R. 2000. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies. Br. Med. J. 321:323-329.
18. Renne, R. A., Yoshimura, H., Yoshino, K., Lulham, G., Minamisawa, S., Tribukait, A., Dietz, D. D., Lee, K. M., and Westerberg, R. B. 2006. Effects of flavoring and casing ingredients on the toxicity of mainstream cigarette smoke in rats. Inhal. Toxicol. 18:685-706.
19. Roemer, E., Stabbert, R., Rustemeier, K., Veltel, D. J., Meisgen, T. J., Reininghaus, W., Carchman, R. A., Gaworski, C. L., and Podraza, K. F. 2004. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195:31-52.
20. Roemer, E., Tewes, F. J., Meisgen, T. L., Veltel, D. J., and Carmines, E. L. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 3: In vitro genotoxicity and cytotoxicity. Food Chem. Toxicol. 40:105-111.
21. Romieu, I., and Trenga, C. 2001. Diet and obstructive lung diseases. Epidemiol. Rev. 23:268-287.
22. Rustemeier, K., Stabbert, R., Haussmann, H. -J., Roemer, E., and Carmines, E. L. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food Chem. Toxicol. 40:93-104. (Pubitemid 33132144)
23. Schramke, H., Meisgen, T. J., Tewes, F. J., Gomm, W., and Roemer, E. 2006. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 227:193-210.
24. Speizer, F. E., Fay, M. E., Dockery, D. W., and Ferris, B. G., Jr., 1989. Chronic obstructive pulmonary disease mortality in six US cities. Am. J. Respir. Crit. Care Med. 140:S49-S55.
25. Sterling, T. D., Rosenbaum, W. L., and Weinkam, J. J. 1993. Risk attribution and tobacco-related deaths. Am. J. Epidemiol. 138:128-139.
26. Talhout, R., Opperhuizen, A., and van Amsterdam, J. G. C. 2006. Sugars as tobacco ingredient: Effects on mainstream smoke composition. Food Chem. Toxicol. 44:1789-1798.
27. Thun, M. J., Day-Lally, C., Myers, D. G., Calle, E. E., Flanders, W. D., Zhu, B. -P., Namboodiri, M. M., and Heath, C. W.Jr., 1997. Trends in tobacco smoking and mortality from cigarette use in cancer prevention studies I (1959 through 1965) and II (1982 through 1988). In Changes in cigarette-related disease risks and their implications for prevention and control, eds. D. R. Shopland, , D. M. Burns, , L. Garfinkel, and J. M. Samet, pp.305-382.
28. Thun, M. J., and Heath, C. W.Jr., 1997. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev. Med. 26:422-426.
29. Tso, T. C. 1992. 9. Maturity, harvesting, and curing. In Production, physiology, and biochemistry of tobacco plant, pp. 105-124. Beltsville, MD: IDEALS, Inc.
30. Vanscheeuwijck, P. M., Teredesai, A., Terpstra, P. M., Verbeeck, J., Kuhl, P., Gerstenberg, B., Gebel, S., and Carmines, E. L. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 4: Subchronic inhalation toxicity. Food Chem. Toxicol. 40:113-131.
31. Viegi, G., Scognamiglio, A., Baldacci, S., Pistelli, F., and Carrozzi, L. 2001. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 68:4-19.
32. Wald, N. J., and Watt, H. C. 1997. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. Br. Med. J. 314:1860-1863.
33. Wayne, G. F., and Connolly, G. N. 2004. Application, function, and effects of menthol in cigarettes: A survey of tobacco industry documents. Nicotine Tobacco Res. 6(Suppl. 1):S43-S54.
34. Wynder, E. L., and Hoffmann, D. 1963. Ein experimenteller Beitrag zur Tabakrauchkanzerogenese (An experimental contribution to tobacco smoke carcinogenesis). Dtsch. Med. Wochenschr. 88:623-628.